Marked increase of the frequency of detection of cancer of the prostate in the Netherlands during the period 1990-1996;Sterke stijging van de detectiefrequentie van prostaatkanker in Nederland gedurende de periode 1990-1996

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 35, 1998, Pages 1958-1962

  Giard, R W M ^a,b   Coebergh, J W W ^a,c   Casparie van Velsen, I J A M G ^a  

^a Medisch Wetenschappelijke Raad   (Netherlands)

^b St Clara Hospital   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PROSTATE ADENOCARCINOMA; TRANSRECTAL ULTRASONOGRAPHY;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032578254     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Middleton RG. Prostate cancer. are we screening and treating too much? Ann Intern Med 1997;126:465-7.
2. Dearnaley DP, Meha J. Early prostate cancer - to treat or not to treat? Lancet 1997;349:892-3.
3. The prostate question, unanswered still. Lancet 1997;349:443.
4. Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997;126:394-406.
5. Visser O, Coebergh JWW, Schouten LJ, Dijk JJ van, editors. Incidence of cancer in the Netherlands 1994. Utrecht: Vereniging van Integrale Kankercentra, 1997.
6. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
7. Jacobsen SJ, Katusic SK, Bergstralh EJ, Oesterling JE, Ohrt D, Klee GG, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 1995;274: 1445-9.
8. Prorok PC, Potosky AL, Gohagan JK, Kramer BS. Prostate cancer screening' current issues. In: Miller AB. editor. Advances in cancer screening. Boston: Kluwer, 1996:93-112.
9. Blasko JC, Lange PH. Prostate cancer - the therapeutic challenge of locally advanced disease. N Engl J Med 1997;337:340-1.
10. Visser O, Horenblas S. Incidentie en behandeling van prostaatcarcinoom in de regio van het Integraal Kankercentrum Amsterdam, 1989-1994. Ned Tijdschr Geneeskd 1996;140:2627-31.
11. Slonim SM, Cuttino jr JT, Johnson O, Yankaskas BG, Smith 3d JJ, Silverman ML, et al. Diagnosis of prostatic carcinoma: value of random transrectal sonographically guided biopsies. Am J Roentgenol 1993;161:1003-6.
12. Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997;49(3A Suppl):113-8.
13. Merrill RM, Potosky AL, Feuer EJ. Changing trends in US prostate cancer incidence rates. J Natl Cancer Inst 1996;88:1683-5.
14. Post PN, Kil PJM, Crommelin MA, Schapers RFM, Coebergh JWW. Trends in incidence and mortality due to prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971-1995. Eur J Cancer 1998;34:705-9.
15. Chu TM. Prostate-specific antigen and early detection of prostate cancer. Tumour Biol 1997;18:123-34.
16. McNaughton Collins M, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. JAMA 1997;278:1516-9.
17. Menon M, Parulkar BG, Baker S. Should we treat localized prostate cancer? An opinion. Urology 1995;46:607-16.
18. Gleason DF. Histologic grade, clinical stage, and patient age in prostate cancer. NCI Monogr 1988;7:15-8.
19. Coebergh JWW, Heijden LH van der, Janssen-Heijnen MLG, editors. Cancer incidence and survival in the Southeast of the Netherlands 1955-1994. Eindhoven: Integraal Kankercentrum Zuid. 1995:108-9.
20. McNaughton Collins M, Barry MJ. Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate. JAMA 1996;276:1976-9.
21. Adami HO, Baron JA, Rothman KJ. Ethics of a prostate cancer screening trial. Lancet 1994;343:958-60.
22. Middleton RG, Thompson IAM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, et al. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 1995;154:2144-8.